Total Payments
$731.39
2022 Payments
$13.43
Companies
17
Transactions
41
Payment Breakdown by Category
Food & Beverage$731.39 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $731.39 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $112.39 | 7 | $0 (2018) |
| ABBVIE INC. | $106.32 | 5 | $0 (2022) |
| Upsher-Smith Laboratories LLC | $69.79 | 4 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $67.34 | 4 | $0 (2017) |
| Biogen, Inc. | $61.85 | 3 | $0 (2018) |
| PFIZER INC. | $48.28 | 3 | $0 (2018) |
| Jazz Pharmaceuticals Inc. | $47.39 | 3 | $0 (2018) |
| Ipsen Biopharmaceuticals, Inc | $35.68 | 2 | $0 (2017) |
| Lilly USA, LLC | $32.24 | 2 | $0 (2019) |
| Eisai Inc. | $21.11 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.43 | 1 | ABBVIE INC. ($13.43) |
| 2021 | $92.89 | 4 | AbbVie Inc. ($92.89) |
| 2019 | $33.29 | 2 | Neurocrine Biosciences, Inc. ($20.94) |
| 2018 | $279.84 | 16 | Allergan Inc. ($52.41) |
| 2017 | $311.94 | 18 | Teva Pharmaceuticals USA, Inc. ($67.34) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Neuroscience | ||||||
| 01/04/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2018 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Neuroscience | ||||||
| 10/22/2018 | Egalet US Inc | SPRIX (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Pain Medicine | ||||||
| 10/12/2018 | GE Healthcare | — | Food and Beverage | Cash or cash equivalent | $13.38 | General |
| 10/10/2018 | Upsher-Smith Laboratories LLC | QUDEXY XR Topiramate Extended Release Capsules (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Neurology | ||||||
| 09/19/2018 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Neurology | ||||||
| 08/13/2018 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/09/2018 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Neurology | ||||||
| 05/04/2018 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: NEUROLOGY | ||||||
| 04/20/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/18/2018 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Sleep | ||||||
| 03/02/2018 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2018 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA, ZINBRYTA | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: NEUROLOGY | ||||||
| 02/16/2018 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $21.11 | General |
| Category: Neurology | ||||||
| 02/02/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/20/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2018 | Upsher-Smith Laboratories LLC | QUDEXY XR Topiramate Extended Release Capsules (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Neurology | ||||||
| 12/07/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Central Nervous System | ||||||
About Dr. Peter Bridgman, M.D
Dr. Peter Bridgman, M.D is a Neurology healthcare provider based in Biddeford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801880943.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Bridgman, M.D has received a total of $731.39 in payments from pharmaceutical and medical device companies, with $13.43 received in 2022. These payments were reported across 41 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($731.39).
Ad
Practice Information
- Specialty Neurology
- Location Biddeford, ME
- Active Since 09/06/2005
- Last Updated 11/27/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1801880943
Products in Payments
- UBRELVY (Drug) $106.32
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $69.79
- COPAXONE (Drug) $67.34
- NAMZARIC (Drug) $63.55
- LYRICA (Drug) $48.28
- Xyrem (Drug) $47.39
- TYSABRI (Biological) $40.73
- VNS Therapy (Device) $35.93
- Dysport 300 U-1 (Drug) $35.68
- VRAYLAR (Drug) $35.19
- EMGALITY (Drug) $32.24
- TECFIDERA (Drug) $21.12
- Fycompa (Drug) $21.11
- AUBAGIO (Drug) $20.97
- INGREZZA (Drug) $20.94
- SPRIX (Drug) $20.11
- Horizant (Drug) $17.67
- BOTOX THERAPEUTIC (Biological) $13.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.